“This is my fourth store!” an exasperated Lisa Shelton said as she stood in the aisle of a Rite Aid on 18th Avenue in Bensonhurst on Sunday, staring at a nearly-empty shelf that normally would be stocked with baby formula. Shelton, who gave birth to a baby boy last month, said she was down to her last two bottles of Similac and was feeling desperate.
The Food and Drug Administration (FDA) decision to lift restrictions on the abortion pill mifepristone — paving the way for women to obtain the pill by mail and self-perform abortions as early as 10 weeks of gestation without an in-person clinic visit — has drawn new criticism from pro-life advocates.
As COVID-19 continues to strike hundreds of thousands of Americans, there are disputes within the medical community on how to treat the drug and whether one particular drug is a cure for the virus.
